Concepedia

Publication | Open Access

A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3

DOIFull Paper Access

17

Citations

31

References

2016

Year

David Shultz, Jonathan Pai, Wayland Chiu, Kendall Ng, Madeline G. Hellendag, Gregory M. Heestand, Daniel T. Chang, Dongsheng Tu, Malcolm J. Moore, Wendy R. Parulekar,
PLoS ONE

Abstract

ClinicalTrials.gov NCT00040183.

References

YearCitations

Page 1